- Global Pharma News & Resources

Press Releases - 2022-04-12

Date Title Company
12-Apr-2022 IQVIA to Announce First-Quarter 2022 Results on April 27, 2022 Businesswire
12-Apr-2022 AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022 Businesswire
12-Apr-2022 Immunicom Announces Addition of Key Industry Leaders to Board of Directors Businesswire
12-Apr-2022 Insights on the Agricultural Biotechnology For Transgenic Crops Global Market to 2027 - Tailored Solutions to Meet the Needs of Each Farmer Presents Opportunities - Businesswire
12-Apr-2022 Worldwide Temperature Controlled Packaging Solutions Industry to 2028 - Size, Share, Outlook, and Opportunity Analysis - Businesswire
12-Apr-2022 Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates Businesswire
12-Apr-2022 Worldwide Invasive Blood Pressure Monitoring Transducers Industry to 2026 - Growing Advancement in Technology is Escalating the Growth of the Market - Businesswire
12-Apr-2022 Global Citric Acid Market Trajectory & Analytics Report 2022: Growing Applications as a Preservative, Acidulant, Binding and Buffering Agent and Antioxidant - Businesswire
12-Apr-2022 Surf Bio Announces $16 Million Series Seed Financing Businesswire
12-Apr-2022 Global Tissue Diagnostics Market Trajectory & Analytics to 2024 - Developed Regions Lead, Developing Economies to Spearhead Growth - Businesswire
12-Apr-2022 United States Clinical Trial Imaging Markets Report 2022-2027: Focus on Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-ray - Businesswire
12-Apr-2022 Aether Biomachines and Allonnia Announce Partnership to Engineer Breakthrough Biological Solutions to Degrade PFAS and Other Harmful Environmental Toxins Businesswire
12-Apr-2022 AscellaHealth’s Hub Solutions for Life Sciences Ensures Specialty Product Access and Market Entry, Optimizes Outcomes for Rare Disease Patients Businesswire
12-Apr-2022 Immune-Onc Therapeutics Doses First Patient in Phase 1 Clinical Trial of IO-202, a First-in-Class Myeloid Checkpoint Inhibitor Targeting LILRB4, in Patients with Advanced Solid Tumors Businesswire
12-Apr-2022 Relevant Industrial Expands Their Partnership With Van London, an Alpha Measurement Solutions Brand Businesswire
12-Apr-2022 MyMD Pharmaceuticals’ Lead Compound MYMD-1 Demonstrates Superior Anti-inflammatory Effects over Top-Selling Therapies in a Pivotal Preclinical Model of Rheumatoid Arthritis Businesswire
12-Apr-2022 Innominds Acquires Nymi, a Leader in Passwordless Workplace Technology Businesswire
12-Apr-2022 United States Addiction Disorder Drugs Market Report 2022: Focus on California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas - Businesswire
12-Apr-2022 Marty Zamora, MD Joins Renovion, Inc. as Chief Medical Officer Businesswire
12-Apr-2022 Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-driven HART CVE Blood Test Highly Accurate in Patients with Diabetes for Predicting Heart Attack, Stroke, and Cardiac Death Risk Businesswire